SOLTF
Price:
$5
Market Cap:
$75.83B
Nxera Pharma Co., Ltd. develops and sells biopharmaceutical products in Japan, Switzerland, the United States, Bermuda, and the United Kingdom. Its product portfolio products include Ultibro/Breezhaler and Seebri/Breezhaler for the treatment of chronic obstructive pulmonary disease; Enerzair and Breezhaler for the treatment of asthma; ORAVI, a novel formulation for the treatment of oropharyngeal candidiasis; and PIVLAZ for the treatment of cerebral vasospasm indications. The company's development products pipeline consists of HTL0039732 for immuno-oncology indications; HTL0048149 for schizophrenia disorders; Daridorexant for the treatment of insomnia; HTL0016878 for schizophrenia and other n...[Read more]
Industry
Biotechnology
IPO Date
2013-09-04
Stock Exchange
OTC
Ticker
SOLTF
According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -21.74. This represents a change of 191.59% compared to the average of -7.46 of the last 4 quarters.
The mean historical PE Ratio of Nxera Pharma Co., Ltd. over the last ten years is 57.82. The current -21.74 PE Ratio has changed -3860.20% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's PE Ratio was at its highest in in the December 2016 quarter at 2.71K. The PE Ratio was at its lowest in in the December 2019 quarter at -1436.15.
Average
57.82
Median
5.70
Minimum
-160.51
Maximum
457.74
Discovering the peaks and valleys of Nxera Pharma Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 201.15%
Maximum Annual PE Ratio = 457.74
Minimum Annual Increase = -1616.21%
Minimum Annual PE Ratio = -160.51
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -19.44 | 19.23% |
| 2023 | -16.30 | -103.56% |
| 2022 | 457.74 | 201.15% |
| 2021 | 152.00 | 58.62% |
| 2020 | 95.83 | -17.51% |
| 2019 | 116.16 | -1616.21% |
| 2018 | -7.66 | -86.95% |
| 2018 | -58.73 | -407.96% |
| 2017 | 19.07 | -111.88% |
| 2016 | -160.51 | -316.91% |
The current PE Ratio of Nxera Pharma Co., Ltd. (SOLTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
140.67
5-year avg
133.96
10-year avg
57.82
Nxera Pharma Co., Ltd.’s PE Ratio is less than GenSight Biologics S.A. (-0.83), less than Basilea Pharmaceutica AG (10.00), less than Viva Biotech Holdings (25.92), greater than MedinCell S.A. (-41.00), greater than 4DMedical Limited (-31.67), less than BioInvent International AB (publ) (-5.84), greater than Race Oncology Limited (-102.81), less than Avacta Group Plc (-20.90), less than ManifestSeven Holdings Corporation (-0.00), less than JCR Pharmaceuticals Co., Ltd. (-15.87),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.83 | $36.12M | |
| 10.00 | $776.07M | |
| 25.92 | $574.30M | |
| -41.00 | $230.71M | |
| -31.67 | $449.02M | |
| -5.84 | $216.40M | |
| -102.81 | $451.73M | |
| -20.90 | $481.37M | |
| -0.00 | $1.71K | |
| -15.87 | $548.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nxera Pharma Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Nxera Pharma Co., Ltd. (SOLTF)?
What is the highest PE Ratio for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 3-year average PE Ratio for Nxera Pharma Co., Ltd. (SOLTF)?
What is the 5-year average PE Ratio for Nxera Pharma Co., Ltd. (SOLTF)?
How does the current PE Ratio for Nxera Pharma Co., Ltd. (SOLTF) compare to its historical average?